[Research Report] The cell line development market was valued at US$ 4,160.42 million in 2019 and is projected to reach US$ 11,219.87 million by 2027; it is expected to grow at a CAGR of 13.3% from 2020 to 2027.
Market Insights and Analyst View:
Cell line development is the process by which the cellular machinery is co-opted to manufacture therapeutic biologics or other proteins of interest. The cell line is an established cell culture where the cells multiply in the appropriate growth medium and space for growth. Cell lines allow gradual alterations in the structure, physiology, and genetic structure of cells under a customized environment. The increasing investments in research and development by pharmaceutical and biotechnology companies, coupled with the increasing adoption of regenerative medicines, are expected to propel the cell line development market growth during the forecast period.
Growth Drivers and Challenges:
In recent years, the cases of cancer have been increasing tremendously and the trend is anticipated to remain the same in the upcoming years. Changes in lifestyle has resulted in more exposure to oncogenic factors. Cancer is one of the leading cause of deaths globally and is profoundly affecting the quality of life. As per World Health Organization in 2020 stats, approximately 10 million deaths across the globe were due to cancer. For instance, as per American Cancer Society, in 2020, there will be an expected 1.8 million new cancer cases detected and 606,520 cancer deaths in the US. Cancer can be cured if diagnosed and treated at an initial stage. Cancer sequencing using next-generation sequencing (NGS) methods provides more information. Additionally, cell line development also aids in research, diagnostics and treatment of cancer.
The increasing involvement of several CDMOs in the cell line development market is propelling the market's growth rate. For instance, ABC Biologics was named the Leading Innovator in mammalian cell line development for the US in 2022, supporting cell line development market growth.
Sino Biological is a contract research organization (CRO) specializing in the recombinant production of proteins and antibodies, with routine high throughput projects of up to 1,000 per batch. Similarly, Aragen Bioscience, Inc, a leading pre-clinical contract research organization, introduced RapTr services. RapTr Cell Line Development Services combine the proven CHO-DG44 host cell line and vector combination with an innovative clone selection process. Multiple numbers of cell line development CRO companies are offering cell line development services, thus propelling market growth.
Thus, above mentioned factors are expected to boost the cell line development market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Line Development Market: Strategic Insights
Market Size Value in US$ 4,160.42 Million in 2019 Market Size Value by US$ 11,219.87 Million by 2027 Growth rate CAGR of 13.3% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell Line Development Market: Strategic Insights
| Market Size Value in | US$ 4,160.42 Million in 2019 |
| Market Size Value by | US$ 11,219.87 Million by 2027 |
| Growth rate | CAGR of 13.3% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The “Global Cell Line Development Market” is segmented based on type, product, application, and geography. Based on type, the cell line development market is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell line. Based on product, the cell line development market is segmented into equipment, media and reagent. Based on application, the cell line development market is segmented into drug discovery, bioproduction, and tissue engineering. The cell line development market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
Based on type, the cell line development market is segmented into primary cell line, hybridomas, continuous cell lines, and recombinant cell line. Recombinant cell line segment held the largest share of the market. Moreover, the hybridomas segment is expected to register the highest CAGR of 14.1% in the market during the forecast period. Recombinant cell lines are preferred systems for the production of therapeutic recombinant proteins. Recombinant mammalian cell lines have been most commonly used for production of recombinant proteins due to its similarity in metabolic and protein processing pathways to those in human cells. Biotherapeutic proteins have been used for treatment of various conditions like infectious diseases, autoimmune disorders, hormonal dysregulation, hematologic disorders, cancers, and genetic disorders. Thus, the growing adoption of recombinant cell line for the production of biotherapeutic recombinant proteins is likely to grow the demand of recombinant cell line during the forecast period.
Cell Line Development Market, by Type – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on application, the cell line development market is segmented into drug discovery, bioproduction, and tissue engineering. In 2019, the bioproduction segment held the largest share of the market. However, the drug discovery segment is expected to register the highest CAGR of 14.3% in the market during the forecast period. Cell lines are the preferred expression systems for producing recombinant, large, complex proteins with post-translational modifications. Chinese hamster ovary (CHO) cell line is the most common mammalian cell line used for production of recombinant protein. Many of the market players are offering cell lines for bioproduction. For instance, Creative Biogene provides comprehensive services for generating bioproduction stable cell lines. Creative Biogene is experience at developing bioproduction cell lines that includes robust vector design and construction, gene synthesis, gene delivery with high efficiency, and rigorous Q&C system etc. Similarly, due to considerable genomic research and development activities, biotherapeutic cell line development has reached new frontiers. In addition, existing and emerging technologies in the biotherapeutics cell line development have played an integral role in pushing cell development market toward new frontiers.
Regional Analysis:
Based on geography, the cell line development market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America cell line development market has been analysed based on three major countries — the US, Canada, and Mexico. The US is estimated to hold the largest cell line development market share during the forecast period. The cell line development market growth in the US is attributed to the various market players, and dynamic scenario has been established in this region have transformed the dynamics of cell line development in the region. The growth in North America is characterized by an increase in the demand for innovative products from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive research and development conducted by various academic and research institutes. Moreover, increasing focus on advanced method incorporation in healthcare, government, and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research are further expected to stimulate growth and contribute to exceptional revenue generation for the cell line development market in North America. The medical biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover, or alter various biomolecules and organisms through bioengineering approaches. The Biotech Startup Revolution has also assisted in promoting the new ventures holding promising and innovative ideas in the country and supported in maximizing the revenue generation and thus the economic position of North America in the global cell line development market.
Furthermore, various launches of technologically advanced product for cell line development are expected to boost market growth. For instance, in October 2021, BICO company introduced CYTENA, a new platform for completely automated stable cell line development. The platform combines CYTENA's best-in-class liquid handling expertise for cost-effective and superior laboratory automation. The democratization of access to the production of next-generation healthcare solutions, such as antibody therapies, gene therapies, and biosimilar production, furthers BICO's Bio Convergence agenda.
Europe is the second leading region in the global cell development market. Germany is holding the largest share in the Europe cell line development market during the forecast period due to the factors such as government and private funding for biotechnology research, the launch of innovative technologies for cell line synthesis, and an increase in various research for novel technology-based applications are likely to be the significant factors driving the growth of this market in this region.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global cell line development market are listed below:
- In July 2022, ProBioGen and Granite Bio collaborated to provide GMP manufacturing and Cell Line Development Services. A novel monoclonal antibody developed by Granite Bio is the company's top candidate for the treatment of autoimmune and specific cancer indications, by using the DirectedLuck transposase.
- In June 2022, FUJIFILM Corporation invested US$ 1.6 billion to enhance and expand the cell culture manufacturing services of FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corporation, and world-leading contract development and manufacturing organization (CDMO). This investment will also expand cell culture manufacturing solutions at the FUJIFILM Diosynth Biotechnologies’ Texas site. FUJIFILM Diosynth Biotechnologies will implement its proprietary SymphonX production equipment, enabling cGMP MaruX continuous processing at the single-use cell culture manufacturing site.
- In April 2019, Lonza introduced CellBio Services, a comprehensive portfolio of unique, custom solutions designed to meet specific, individual research application needs.
- In June 2019, Thermo Fisher Scientific launhced Cytomat 2 C-LiN Series automated incubator for cell cultures. This instrument has specifications such as automated controlled humidity, in-built contamination reduction system, and other advanced features.
- In October 2019, Merck acquired FloDesign Sonics a US based company. FloDesign Sonics is a developer of distinctive acoustic cell processing platform that is applicable for the industrialization of cell and gene therapy manufacturing.
Covid-19 Impact:
As per the study titled "Scientists develop suitable human cell line for anti-SARS-CoV-2 drug screening" published in the Journal Viruses in June 2022, Researchers have described the creation of a suitable human cell line for the high-throughput testing of antiviral medications that target the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2). Angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), two essential host proteins required for viral entry, were engineered to express high levels in the human lung carcinoma cell line A549. Resulting, development of more cell lines to manage COVID-19, which had a significant impact on the cell line development market during the pandemic.
Competitive Landscape and Key Companies:
Some of the prominent players operating in the global cell line development market include Thermo Fisher Scientific Inc., Merck KGaA, Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius AG, Lonza, GENERAL ELECTRIC, LakePharma, Inc., and WuXi AppTec Group among others. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their cell line development market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type ; By Product ; Application ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The cell line development market majorly consists of the players such as Merck KGaA, Thermo Fisher Scientific Inc., Selexis SA (JSR Corporation), BioFactura, Inc., Corning Incorporated, Sartorius AG, Lonza, GENERAL ELECTRIC, LakePharma, Inc., and WuXi AppTec Group amongst others.
The cell line is established cell culture, which gets increased numerous times when supplied with the growth medium and space for growth. Different cell lines can be made from different cells. The cell line plays a vital role in the study of cytology. The cell line enables stepwise alterations in the structure, physiology, and genetic makeup of cells under a customized environment.
The factors that are driving growth of the market are Increasing adoption of regenerative medicines, rising prevalence of cancer across the globe and increasing investments in R&D by pharmaceutical and biotechnology companies. Moreover, consistent research in drug discovery activities are offering lucrative opportunities for the growth of the market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cell Line Development Market – By Type
1.3.2 Global Cell Line Development Market – By Product
1.3.3 Global Cell Line Development Market – By Application
1.3.4 Global Cell Line Development Market – By Geography
2. Cell Line Development Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cell Line Development – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Line Development Market in North America: PEST Analysis
4.2.2 Cell Line Development Market in Europe: PEST Analysis
4.2.3 Cell line development Market in APAC: PEST Analysis
4.2.4 Cell Line Development Market in MEA: PEST Analysis
4.2.5 Cell Line Development Market – South and Central America PEST Analysis
4.3 Expert Opinion
5. Global Cell Line Development Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Regenerative Medicines
5.1.2 Rising Prevalence of Cancer
5.1.3 Growing Investment in R&D by Pharmaceutical and Biotechnology Companies
5.2 Key Restraints
5.2.1 Risk Associated with Cell Line Contamination
5.3 Key Opportunity
5.3.1 Middle Income Countries Creating Development Opportunities
5.4 Future Trend
5.4.1 Consistent Research in Drug Discovery Activities
5.5 Impact Analysis
6. Cell Line Development Market – Global Analysis
6.1 Global Cell Line Development Market Revenue Forecast and Analysis
6.2 Global Cell Line Development Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.3.1 Merck KGaA
6.3.2 Thermo Fisher Scientific Inc.
7. Cell Line Development Market - Revenue and Forecasts to 2027 – Type
7.1 Overview
7.2 Global Cell Line Development Market, by Type, 2019 & 2027 (% Share)
7.3 Primary Cell Line
7.3.1 Overview
7.3.2 Global Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Hybridomas
7.4.1 Overview
7.4.2 Global Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Continuous Cell Lines
7.5.1 Overview
7.5.2 Global Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Recombinant Cell Line
7.6.1 Overview
7.6.2 Global Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
8. Cell Line Development Market Analysis and Forecasts to 2027 – Product
8.1 Overview
8.2 Global Cell Line Development Market, by Product, 2019 & 2027 (% Share)
8.3 Equipment
8.3.1 Overview
8.3.2 Global Equipment Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Media and Reagent
8.4.1 Overview
8.4.2 Global Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
9. Cell Line Development Market Analysis and Forecasts to 2027 – Application
9.1 Overview
9.2 Global Cell Line Development Market Share by Application 2019 & 2027 (%)
9.3 Drug Discovery
9.3.1 Overview
9.3.2 Global Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Bioproduction
9.4.1 Overview
9.4.2 Global Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Tissue Engineering
9.5.1 Overview
9.5.2 Global Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
10. Cell Line Development Market Revenue and Forecast to 2027 – Geographical Analysis
10.1 North America Cell Line Development Market, Revenue and Forecast to2027
10.1.1 Overview
10.1.2 North America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.3 North America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.4 North America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.5 North America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.6 North America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.1.7 US
10.1.7.1 US Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.7.2 US Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.7.3 US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.7.4 US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.8 Canada
10.1.8.1 Canada Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.8.2 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.8.3 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.8.4 Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.1.9 Mexico
10.1.9.1 Mexico Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.1.9.2 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.1.9.3 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.1.9.4 Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2 Europe Cell Line Development Market Revenue and Forecast to 2027
10.2.1 Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.2 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.3 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.4 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.5 Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.2.6 Germany
10.2.6.1 Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.6.2 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.6.3 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.6.4 Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.7 UK
10.2.7.1 UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.7.2 UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.7.3 UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.7.4 UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.8 France
10.2.8.1 France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.8.2 France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.8.3 France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.8.4 France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.9 Spain
10.2.9.1 Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.9.2 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.9.3 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.9.4 Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.2.10 Italy
10.2.10.1 Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.2.10.2 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.2.10.3 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.2.10.4 Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3 APAC Cell Line Development Market, Revenue and Forecast to 2027
10.3.1 Overview
10.3.2 APAC Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.3 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.4 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.5 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.6 APAC Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.3.7 China
10.3.7.1 China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.7.2 China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.7.3 China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.7.4 China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.8 Japan
10.3.8.1 Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.8.2 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.8.3 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.8.4 Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.9 India
10.3.9.1 India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.9.2 India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.9.3 India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.9.4 India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.10 South Korea
10.3.10.1 South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.10.2 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.10.3 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.10.4 South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.3.11 Australia
10.3.11.1 Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.3.11.2 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.3.11.3 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.3.11.4 Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4 MEA Cell Line Development Market, Revenue and Forecast to 2027
10.4.1 Overview
10.4.2 MEA Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.3 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.4 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.5 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4.6 MEA Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.4.7 UAE
10.4.7.1 UAE Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.7.2 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.7.3 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.7.4 UAE Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4.8 Saudi Arabia
10.4.8.1 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.8.2 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.8.3 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.8.4 Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.4.9 South Africa
10.4.9.1 South Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.4.9.2 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.4.9.3 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.4.9.4 South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.5 South and Central America Cell Line Development Market, Revenue and Forecast to 2027
10.5.1 Overview
10.5.2 South and Central America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.3 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.5.4 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.5.5 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.5.6 South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
10.5.7 Brazil
10.5.7.1 Brazil Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.7.2 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.5.7.3 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.5.7.4 Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
10.5.8 Argentina
10.5.8.1 Argentina Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
10.5.8.2 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
10.5.8.3 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
10.5.8.4 Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
11. Impact Of COVID-19 Pandemic on Global Cell Line Development Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Cell Line Development Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in The Market, (%)
12.3 Organic Developments Done by The Companies in the Market
12.4 Inorganic Developments Done by The Companies in the Market
13. Cell Line Development Market– Key Company Profiles
13.1 Merck KGaA
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Thermo Fisher Scientific, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Information
13.2.4 Product /Services Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Sartorius AG
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 SELEXIS
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product/Service Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioFactura, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 WuXi AppTec
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Overview
13.6.4 Service Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 LakePharma, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 General Electric
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lonza
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Information
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Corning Incorporated
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 2. North America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 3. North America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 4. US Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 5. US Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 6. US Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 7. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 8. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 9. Canada Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 10. Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 11. Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 12. Mexico Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 13. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 14. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 15. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 16. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 17. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 18. Germany Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 19. UK Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 20. UK Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 21. UK Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 22. France Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 23. France Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 24. France Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 25. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 26. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 27. Spain Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 28. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 29. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 30. Italy Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 31. APAC Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 32. APAC Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 33. APAC Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 34. China Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 35. China Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 36. China Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 37. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 38. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 39. Japan Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 40. India Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 41. India Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 42. India Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 43. South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 44. South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 45. South Korea Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 46. Australia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 47. Australia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 48. Australia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 49. MEA Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 50. MEA Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 51. MEA Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 52. UAE Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 53. UAE Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 54. UAE Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 55. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 56. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 57. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 58. South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 59. South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 60. South Africa Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 61. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 62. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 63. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 64. Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 65. Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 66. Brazil Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 67. Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Type (US$ Mn)
Table 68. Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Product (US$ Mn)
Table 69. Argentina Cell Line Development Market, Revenue and Forecast to 2027, By Application (US$ Mn)
Table 70. Organic Developments Done by the Companies
Table 71. Inorganic Developments Done by the Companies
Table 72. Glossary of Terms, Cell Line Development Market
LIST OF FIGURES
Figure 1. Cell Line Development Market Segmentation
Figure 2. Cell Line Development Market Segmentation, By Region
Figure 3. Global Cell Line Development Market Overview
Figure 4. Recombinant Cell Line Segment Held Largest Share of Type Segment in Cell Line Development Market
Figure 5. Asia Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Cell Line Development Market, By Geography (US$ Mn)
Figure 7. Global Cell Line Development Market- Leading Country Markets (US$ Mn)
Figure 8. Global Cell Line Development Market, Industry Landscape
Figure 9. Cell Line Development Market in North America: PEST Analysis
Figure 10. Cell Line Development Market in Europe: PEST Analysis
Figure 11. Cell line development Market in APAC: PEST Analysis
Figure 12. Cell Line Development Market MEA: PEST Analysis
Figure 13. Cell Line Development Market – South and Central America PEST Analysis
Figure 14. Most Prevalent Forms of Cancers Globally, 2018
Figure 15. Cell Line Development Market Impact Analysis of Driver and Restraints
Figure 16. Global Cell Line Development Market – Revenue Forecast and Analysis – 2019- 2027
Figure 17. Global Cell Line Development Market – By Geography Forecast and Analysis – 2019- 2027
Figure 18. Market Positioning of Key Players in Global Cell line development Market
Figure 19. Global Cell Line Development Market, Type, 2019 & 2027 (% Share)
Figure 20. Global Primary Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 21. Global Hybridomas Market Revenue and Forecast to 2027 (US$ Mn)
Figure 22. Global Continuous Cell Lines Market Revenue and Forecast to 2027 (US$ Mn)
Figure 23. Global Recombinant Cell Line Market Revenue and Forecast to 2027 (US$ Mn)
Figure 24. Global Cell Line Development Market, By Product, 2019 & 2027 (% Share)
Figure 25. Global Equipment Market Revenue and Forecast to 2027 (US$ Mn)
Figure 26. Global Media and Reagent Market Revenue and Forecast to 2027 (US$ Mn)
Figure 27. Global Cell Line Development Market Share by Application 2019 & 2027 (%)
Figure 28. Global Drug Discovery Market Revenue and Forecast to 2027 (US$ Mn)
Figure 29. Global Bioproduction Market Revenue and Forecast to 2027 (US$ Mn)
Figure 30. Global Tissue Engineering Market Revenue and Forecast to 2027 (US$ Mn)
Figure 31. North America Cell Line Development Market Overview, By Country — 2019 (US$ Mn)
Figure 32. North America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 33. North America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
Figure 34. US Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 35. Canada Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 36. Mexico Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 37. Europe Cell Line Development Market Revenue, By Country, 2019 (US$ Mn)
Figure 38. Europe Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 39. Europe Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
Figure 40. Germany Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 41. UK Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 42. France Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 43. Spain Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 44. Italy Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 45. APAC Cell Line Development Market Revenue Overview, By Country (2019) (US$ Mn)
Figure 46. APAC Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 47. APAC Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
Figure 48. China Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 49. Japan Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 50. India Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 51. South Korea Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 52. Australia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 53. MEA Cell Line Development Market, Revenue Overview, By Country, 2019 (US$ Mn)
Figure 54. MEA Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 55. MEA Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
Figure 56. UAE Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 57. Saudi Arabia Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 58. South Africa Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 59. South and Central America Cell Line Development Market, Revenue Overview, By Country, 2019 (US$ Mn)
Figure 60. South and Central America Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 61. South and Central America Cell Line Development Market, Revenue and Forecast to 2027, By Country (%)
Figure 62. Brazil Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 63. Argentina Cell Line Development Market, Revenue and Forecast to 2027 (US$ Mn)
Figure 64. Impact of COVID-19 Pandemic in North American Country Markets
Figure 65. Impact of COVID-19 Pandemic in European Country Markets
Figure 66. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 67. Impact Of COVID-19 Pandemic in Rest of the World Market
Figure 68. Growth Strategies Done by the Companies in The Market, (%)
The List of Companies - Cell Line Development Market
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Selexis SA (JSR Corporation)
- BioFactura, Inc.
- Corning Incorporated
- Sartorius AG
- Lonza
- GENERAL ELECTRIC
- LakePharma, Inc.
- WuXi AppTec Group
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Cell Line Development Market
Sep 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Sep 2020